PART1 and colorectal cancer: Similarly, PART1 was shown to promote malignant progression of colorectal cancer through the miR-150-5p/LRG1 axis [56] and by sponging miR-150-5p to up-regulate the expression of CTNNB1 and activate Wnt/β-catenin signaling [57].